Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference

Rhea-AI Summary

Autonomix Medical, Inc. (AMIX) CEO to present at MedInvest Biotech & Pharma Investor Conference on April 4th, 2024.

Live webcast presentation on Thursday, April 4^th at 3:55 PM ET

THE WOODLANDS, TX, March 27, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that Lori Bisson, Chief Executive Officer of Autonomix, will present at the MedInvest Biotech & Pharma Investor Conference being held in New York City, NY on Thursday, April 4, 2024 at 3:55 PM ET.

In addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the event, please visit the conference website.

A live webcast of the event will be available on the Events page of the Investors section of the Company’s website (www.autonomix.com).

About Autonomix Medical, Inc.

Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.

We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.

For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.

Investor and Media Contact
JTC Team, LLC
Jenene Thomas
833-475-8247
autonomix@jtcir.com

FAQ

When is the live webcast presentation for Autonomix Medical, Inc.?

The live webcast presentation is scheduled for Thursday, April 4th, 2024, at 3:55 PM ET.

What is the focus of Autonomix Medical, Inc. as a company?

Autonomix is a medical device company dedicated to advancing innovative technologies for diagnosing and treating diseases related to the nervous system.

Who will be presenting at the MedInvest Biotech & Pharma Investor Conference on April 4th, 2024?

Lori Bisson, the Chief Executive Officer of Autonomix Medical, Inc., will be presenting at the conference.

Where will the MedInvest Biotech & Pharma Investor Conference take place?

The conference will be held in New York City, NY.

Will there be one-on-one meetings available with Autonomix management at the conference?

Yes, management will be available for one-on-one meetings with qualified members of the investor community who are registered to attend the conference.